GLP-1 agonists, such as ROSE-010, relieve pain in IBS patients by altering gut motility (43), lowering inflammation (44), modulating neurotransmitters (45), reducing visceral hypersensitivity (46), and interacting with the gut microbiota (47)
The published Phase 2 obesity trial used 24 weeks as the primary endpoint and 48 weeks as a secondary endpoint
Ozempic may interact negatively with sulfonylureas, insulins, and thyroid medications
Aim for balanced meals containing adequate protein, complex carbohydrates, healthy fats, and vegetables
Skip or minimize: rice, cheese, sour cream, queso, and chips
This is not a direct result of the medication, but rather one of the bodys ways of responding to weight and metabolic changes